Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep-Oct;8(6):647-652.
Epub 2017 Sep 1.

Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia

Affiliations
Review

Venetoclax: A Novel Treatment for Patients With del(17p) Chronic Lymphocytic Leukemia

Michelle A Borg et al. J Adv Pract Oncol. 2017 Sep-Oct.
No abstract available

PubMed Disclaimer

Figures

Table 1
Table 1
Dosing Schedule for Ramp-up Phase With Venetoclax
Table 2
Table 2
Recommended Tumor Lysis Syndrome Prophylaxis Based on Tumor Burden
Table 3
Table 3
Dose Modifications for Toxicity With Venetoclax
Table 4
Table 4
Select Adverse Reactions to Venetoclax

References

    1. American Cancer Society. Cancer Facts & Figures 2017. 2017 Retrieved from https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-....
    1. Genentech. Venclexta (venetoclax) tablets package insert. 2016 Retrieved from http://www.rxabbvie.com/pdf/venclexta.pdf.
    1. National Cancer Institute. SEER Cancer Statistics Factsheets: Chronic lymphocytic leukemia. 2016 Retrieved from http://seer.cancer.gov/statfacts/html/clyl.html.
    1. National Comprehensive Cancer Center. NCCN Clinical Practice Guidelines in Oncology: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. V1.2017. 2016 Retrieved from http;//www.nccn.org.
    1. Packham Graham, Stevenson Freda K. Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology. 2005;114:441–449. - PMC - PubMed

LinkOut - more resources